Intiva Biopharma
Manufacturing · Colorado, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4340 E Kentucky Ave Ste 206, Glendale, C...Phone Number
(303) 495-7583Website
www.nexienbiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Intiva Biopharma
Nexien BioPharma is a pharmaceutical company focused on the research and development of cannabinoid-based medications in compliance with FDA regulatory pathways. They develop, license, and commercialize cannabinoid medications for various medical conditions, as well as proprietary delivery systems for accurate dosing. The company also invests in other firms and technologies related to cannabinoid research through controlled Special Purpose Vehicles. Their target clients include healthcare providers and patients needing physician-prescribed cannabinoid therapies.Explore more
Intiva Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Intiva Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Intiva Biopharma had a recent Job posting/layoffs
Intiva Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Intiva Biopharma is spiking on competitors!
Funding: Get notified immidiatlly once Intiva Biopharma has new funding data
Check if Intiva Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Intiva Biopharma recently announced quarterly report
Product Launch: Get notified when Intiva Biopharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Intiva Biopharma
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Intiva Biopharma
Find more new buyers
Compare Similar Companies to Intiva Biopharma
Compare insights from companies similar to Intiva Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Intiva Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Intiva Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Intiva Biopharma.
Intiva Biopharma Tech Stack
A closer look at the technologies used by Intiva Biopharma
Intiva Biopharma News & Media
Intiva BioPharma Comments on Attorney General Jeff Sessions' Actions on January 4th that Affect State-Licensed Cannabis Businesses
Intiva BioPharma Indicated That Sessions' Actions in No Way Affect Its Drug Development Activities, Nor Its Current or Contemplated Business Plans DENVER, CO / ACCESSWIRE / February 5, 2018 / Intiva BioPharma Inc. (OTC PINK: NTVA) ("Intiva" or the "Company") today commented on the January 4, 2018 announcement by U.S. Attorney General Jeff Sessions and the Department of Justice related to state-licensed cannabis companies in the United States. Intiva is a U.S.-based biopharmaceutical company enga
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Intiva Biopharma
Sign Up For FreeTo access detailed company insights
Nexien BioPharma is a pharmaceutical company focused on the research and development of cannabinoid-based medications in compliance with FDA regulatory pathways. They develop, license, and commercialize cannabinoid medications for various medical conditions, as well as proprietary delivery systems for accurate dosing. The company also invests in ot... Read More
